Can we assess Cancer Waiting Time targets with cancer survival? A population-based study of individually linked data from the National Cancer Waiting Times monitoring dataset in England, 2009-2013.
BACKGROUND:Cancer Waiting Time targets have been integrated into successive cancer strategies as indicators of cancer care quality in England. These targets are reported in national statistics for all cancers combined, but there is mixed evidence of their benefits and it is unclear if meeting Cancer...
Main Authors: | Chiara Di Girolamo, Sarah Walters, Carolynn Gildea, Sara Benitez Majano, Bernard Rachet, Melanie Morris |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC6104918?pdf=render |
Similar Items
-
Genetic progression and the waiting time to cancer.
by: Niko Beerenwinkel, et al.
Published: (2007-11-01) -
Characteristics of patients with missing information on stage: a population-based study of patients diagnosed with colon, lung or breast cancer in England in 2013
by: Chiara Di Girolamo, et al.
Published: (2018-05-01) -
Waiting times for prostate cancer: a review
by: Giacomo Lazzeri, et al.
Published: (2020-06-01) -
The Waiting Time of Prostate Cancer Patients in Poland
by: Karolina Osowiecka, et al.
Published: (2019-01-01) -
Waiting time for radiotherapy in women with cervical cancer
by: Maria Isabel do Nascimento, et al.
Published: (2015-01-01)